Precision BioSciences, Inc.

NASDAQ:DTIL

Biotechnology

Healthcare
$6.91 +1.69%

+$0.11 today

Market cap
$193.04M
Beta
1.28
P/E (TTM)
-1.9
EPS (TTM)
-$3.47
52W Low $3.53High $8.82

Volume 0.27M

Average 0.31M

Income Statement

Follow revenue through to earnings.

Revenue

$34.26M

FY 2025 · Annual

-50.1% YoY

Operating Income

-$52.15M

FY 2025 · Annual

Net Income

-$46.61M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue115.53M25.1M48.73M68.7M34.26M
Cost of Revenue00002.75M
Gross Profit115.53M25.1M48.73M68.7M31.51M
Gross Margin100.0%100.0%100.0%100.0%92.0%
Research & Development115.24M46.12M53.38M59.56M54.17M
Selling, General & Admin39.67M41.28M39.09M35.3M32.24M
Operating Expenses154.91M87.41M92.46M94.86M83.66M
Depreciation & Amortization10.2M9M8.26M4.58M2.75M
EBITDA(20.27M)(62.79M)(32.04M)13.53M(42.43M)
EBITDA Margin-17.5%-250.2%-65.8%19.7%-123.8%
Operating Income(39.38M)(62.31M)(43.74M)(26.16M)(52.15M)
Operating Margin-34.1%-248.3%-89.8%-38.1%-152.2%
Interest Income208K3.47M7.69M6.76M4.24M
Interest Expense132K1.11M2.23M1.78M1.42M
Other Income / Expenses8.77M(10.6M)1.21M33.33M5.54M
Income Before Tax(30.6M)(72.91M)(42.53M)7.17M(46.61M)
Pre-Tax Margin-26.5%-290.5%-87.3%10.4%-136.0%
Income Tax Expense00000
Net Income(30.6M)(111.64M)(61.32M)7.17M(46.61M)
Net Margin-26.5%-444.8%-125.8%10.4%-136.0%
EPS (Basic)(15.60)(38.10)(15.96)1.05(3.63)
EPS (Diluted)(15.60)(38.10)(15.96)1.04(3.63)
Weighted Avg Shares1.96M2.93M3.84M6.83M12.83M
Weighted Avg Shares (Diluted)1.96M2.93M3.84M6.88M12.83M

DTIL Earnings Waterfall · TTM

NASDAQ:DTIL · Revenue to Net Income

Key Ratios

EPS$-4.41
Gross Margin-867.2%
Net Margin-74564.4%
P/E Ratio-0.4
P/S Ratio1900.9

Analysis

$45.1M of revenue converted into -$44.5M of net income for the selected period. Gross margin is -867.2% and net margin is -74564.4%, showing how much revenue survives after costs and taxes. EPS is $-4.41, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 12, 2026
8-KCurrent reportNov 9, 2026
424B5424B5 filingNov 6, 2026
8-KCurrent reportNov 6, 2026
FWPFWP filingNov 5, 2026

How much revenue does DTIL generate?

Precision BioSciences, Inc. (DTIL) reported $34.26M of revenue in fiscal 2025.

Is DTIL profitable?

Precision BioSciences, Inc. (DTIL) reported -$46.61M of net income, with a net margin of -136.0%.